Format

Send to

Choose Destination
Int J Health Care Finance Econ. 2007 Sep;7(2-3):73-111.

End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).

Author information

1
George Washington University, School of Public Health and Health Services, Washington, DC, USA. avidor@gwu.edu

Abstract

End-stage renal disease (ESRD) is a debilitating, costly, and increasingly common condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care. This paper presents results from a comparative review of 12 countries with alternative models of incentives and benefits, collected under the International Study of Health Care Organization and Financing, a substudy within the Dialysis Outcomes and Practice Patterns Study. Variation in spending per ESRD patient is relatively small, but correlated with overall per capita health care spending. Remaining differences in costs and outcomes do not seem strongly linked to differences in incentives.

PMID:
17653860
DOI:
10.1007/s10754-007-9024-9
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center